Avadel Pharma
AVDL21.6400.00% ( 0.000 )
Q3 FY2025 Earnings
Financial report interval: 2025.06.30 - 2025.09.30
Overview: Avadel Pharma(AVDL) the Revenue is 77.47 M (+54.86%);the EBIT is 1.937 M (+692.4%);the EPS is 0.0002 (+100.7%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.08B54.86%
----
----
EBIT
0.00B692.35%
----
----
EPS
0.0002100.66%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf